期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
无痛胃镜检查时布托啡诺抑制吞咽反射ED50和ED95的测定 被引量:7
1
作者 胡君凤 胡双燕 +4 位作者 仲俊峰 叶钢 毛琳玲 邱凯 陈栋樑 《中国内镜杂志》 2022年第2期63-67,共5页
目的测定不同剂量丙泊酚复合布托啡诺无痛胃镜检查时,布托啡诺抑制吞咽反射的ED50和ED95值。方法将76例无痛胃镜检查患者随机分为P1组和P2组,P1组给予丙泊酚2.0 mg/kg复合布托啡诺静脉麻醉,P2组给予2.5 mg/kg丙泊酚复合布托啡诺静脉麻... 目的测定不同剂量丙泊酚复合布托啡诺无痛胃镜检查时,布托啡诺抑制吞咽反射的ED50和ED95值。方法将76例无痛胃镜检查患者随机分为P1组和P2组,P1组给予丙泊酚2.0 mg/kg复合布托啡诺静脉麻醉,P2组给予2.5 mg/kg丙泊酚复合布托啡诺静脉麻醉。布托啡诺初始剂量为5.0μg/kg,根据吞咽反射抑制情况,运用Dixon序贯法确定下一例患者使用剂量,应用Probit分析得出两组患者布托啡诺抑制吞咽反射ED50和ED95值。结果P2组低血压发生率明显高于P1组(P<0.05);P1组和P2组布托啡诺抑制吞咽反射的ED50分别为3.5μg/kg(95%CI:2.9~4.1)和3.1μg/kg(95%CI:2.4~3.5);P1组和P2组抑制吞咽反射的ED95分别为5.8μg/kg(95%CI:4.7~15.9)和5.0μg/kg(95%CI:4.1~12.3)。结论布托啡诺复合丙泊酚2.0和2.5 mg/kg无痛胃镜检查时,抑制吞咽反射的ED50分别为3.5和3.1μg/kg,ED95分别为5.8和5.0μg/kg,对临床无痛胃镜麻醉用药具有指导意义。 展开更多
关键词 布托啡诺 ED50 ED95 胃镜 吞咽反射
下载PDF
Organocatalytic Copolymerization of Mixed Type Monomers 被引量:4
2
作者 Qi-lei Song shuang-yan hu +1 位作者 赵俊鹏 Guang-zhao Zhang 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2017年第5期581-581,582-601,共21页
Triggered by environmental concerns and the rising demands for metal-free polymers in e.g. bio-related and microelectronic applications, studies on organocatalytic polymerization have been launched and developed unpre... Triggered by environmental concerns and the rising demands for metal-free polymers in e.g. bio-related and microelectronic applications, studies on organocatalytic polymerization have been launched and developed unprecedentedly during the last 15 years. A wide range of organic molecules are now available in polymer chemists' toolbox to choose from as catalysts for polymerization of (hetero)cyclic and polar vinyl monomers. Apart from the intrinsic merits such as lower toxicity and better solubility compared with (transition) metal catalysts/initiators, organocatalysts have also shown, in many cases, excellence to achieve high polymerization rates and/or good control (selectivity). In addition, particular natures and catalytic/activating mechanisms of organocatalysts have led to new opportunities for rational design and efficient synthesis of macromolecular architectures, i.e. chain structures, topological structures and functionalities. This mini-review is specially themed on pathways to construct copolymer chain structures by organocatalytic copolymerization of mixed type monomers (comonomers bearing different polymerizing moieties) and will be sectioned by different comonomer combinations, including cyclic monoesters of different sizes, cyclic monoesters and lactides, cyclic esters and cyclic carbonates or epoxides, heterocycles and vinyl monomers. 展开更多
关键词 Chain structure COPOLYMER Organocatalytic polymerization
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部